Astrotech reports Q2 EPS ($2.45) vs. ($1.62) last year

Reports revenue $261,000 vs. $1.1M last year. Thomas Pickens, III, CEO said “We are now prioritizing and accelerating our attention to selling and marketing our line of portable, rugged and inexpensive mass spectrometry instruments. We believe 1st Detect’s explosive trace detection products are now proven with four years of use in cargo warehouses having run thousands of samples at airports in 14 countries. Using this same proven and rugged mass spectrometry technology, we have recently introduced 1st Detect’s narcotics trace detector. Fentanyl is one of the most difficult of the drugs to identify and the TRACER NTD is able to differentiate between fentanyl, heroin, THC and methamphetamine with a high degree of accuracy. The Pro-Control line of products helps chemical manufacturers better control the industrial production process to increase yields and profits. With our newest product lines, the TRACER NTD and Pro-Control, we believe we are entering large markets in need of our technology.”